Used in the treatment of HER2-positive breast cancer, particularly in patients who have already received other chemotherapy regimens. It works by inhibiting tyrosine kinases, including HER2 and EGFR, which are involved in cancer cell growth and survival. Often combined with other drugs like capecitabine to enhance effectiveness. Also studied in combination therapies for advanced or metastatic breast cancer to delay disease progression.